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Abstract: Hfq is a bacterial protein that regulates gene expression at the post-transcriptional level
in Gram-negative bacteria. We have previously shown that Escherichia coli Hfq protein, and more
precisely its C-terminal region (CTR), self-assembles into an amyloid-like structure in vitro. In the
present work, we present evidence that Hfq unambiguously forms amyloid structures also in vivo.
Taking into account the role of this protein in bacterial adaptation and virulence, our work opens
possibilities to target Hfq amyloid self-assembly and cell location, with important potential to block
bacterial adaptation and treat infections.
Keywords: bacterial amyloid; functional amyloid; protein fibrils; protein fibrillation inhibition;
Hfq; FTIR
1. Introduction
Antibiotic resistance is one of the most urgent risks to the public’s health. It occurs when
bacteria develop mechanisms to defeat compounds designed to kill them [1]. Recent research for
new antibiotics explores potential compounds that target proteins involved in bacterial adaptation
to their environment [2]. Such adaptation allows bacteria to survive in their host and infection to
progress. To achieve this goal, bacteria commonly use regulation at the post-transcriptional level [3,4].
In vivo, a protein called Hfq is often required for such a regulation. Hfq, standing for Host Factor
Qβ bacteriophage, is a bacterial protein involved in many cellular pathways, including sugar uptake,
iron acquisition, bacterial virulence or pathogenicity [5–10]. Indeed, Hfq is a pleiotropic regulator that
controls gene expression using noncoding RNAs (ncRNA) as cofactors [11]. ncRNAs from different
species have been identified and among them, those from bacteria are ~100 nucleotides long, hence
their name of small RNA (sRNA) [12,13]. Hfq-linked sRNAs function by base pairing with regions
around the translation initiation signal of an associated mRNA target and therefore act on both mRNA
translation and stability [14,15]. In vivo, Hfq is required for sRNA-based regulation as it promotes
annealing of the regulatory sRNA to its cognate mRNA [11,16]. Hfq pleiotropic function is thus
related to the diversity of sRNA-mRNA targets (see as an example multiple targets of only one sRNA,
DsrA [17–19]). Among these targets, nearly half of sRNAs regulate the expression of membrane
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proteins or of proteins involved in membrane-related processes, including proteins involved in the
control of virulence [20–22]. A part of the Hfq protein is thus needed at the periphery of the cell, and
an important fraction of it is indeed located in the proximity of the bacterial inner membrane [23–25].
Structurally, Hfq adopts an Sm-like structure, comprising about 65 amino acids residues, which
folds into a five-stranded antiparallel β-sheet capped by an N-terminal α helix [26]. The β-strands of
adjacent monomers assemble into a continuous intermolecular β-sheet to form a torus [26]. Hfq differs
from eukaryotic Sm proteins in that Sm proteins fold into a heptameric torus, while Hfq proteins form
a 66 kDa homo-hexamer [27]. Until now, all atomic structures of E. coli Hfq, composed of 102 amino
acids, lack its C-terminal region (CTR) composed of 38 amino acids [11].
Hfq forms organized nano-assemblies in vivo, associated with the membrane, whose cellular pattern
resembles that of long-range bacterial cytoskeletal structures [24,25]. Strikingly, these nanostructures are
observable only in the presence of Hfq CTR [24], an apparently intrinsically disordered fragment that
spontaneously forms amyloid structures in vitro [24,28,29]. These amyloid structures form for both
the full-length protein and the isolated CTR region [24,30]. Even if the role of this disordered CTR is
controversial for RNA-based regulation, it has been clearly established to increase hexamer stability,
to modulate DNA compaction and to affect membrane integrity [29,31–34]. Nevertheless, evidence
in vivo for the formation of this bacterial amyloid structure is still lacking.
In this study, we show unambiguously that Hfq CTR forms an amyloid structure in vitro but
also in vivo. Fourier transform infrared (FTIR) spectroscopy, a well-established tool for characterizing
protein secondary and tertiary structure (through the amide I and amide II bands, respectively) has
been used. Infrared spectroscopy indeed provides important contributions in the field of protein
molecular structure and mechanisms. Main advantages of this technique are time resolution (<1 µs),
and applicability from small to large protein complexes, hydrated or as dried samples. Using this
technique, we already showed that Hfq-CTR has an intrinsic property to self-assemble independently
of the rest of the protein [24]. In parallel, we also showed previously that the secondary structure of
amyloid fibrils differs from native proteins in several conditions [35,36]. This difference, that can be
seen in the amide I region of the IR-spectrum, is linked to the packing of β strands and possibly to
the torsion of β sheets. Thus, the presence of amyloid fibrils is usually detected in the 1615 cm−1 to
1625 cm−1 region of the amide I band, whereas native β-sheets absorb more in the 1630 cm−1 and
1675 cm−1 regions [37,38].
2. Results and Discussion
2.1. FTIR spectra and Variance Between Hfq Mutated Strains
Taking into account the nanostructures made by Hfq in vitro and their sub-membrane clustering
in the cell [24], we investigated the possibility of detecting in vivo the FTIR signal associated with
Hfq β-amyloid structure. Intracellular amyloids are usually confirmed using fluorescent dyes such
as Thioflavin S/T (ThT/S) or derivative on fixed bacteria [39,40]. Indeed, the use of thioflavin is a
widely used method to detect the presence of amyloid fibrils in vivo or in vitro [41]. Nevertheless,
we observed previously that ThT staining results in Hfq amyloid fiber disassembly [28,42]. In addition
and contrast, thioflavin has been reported also to promote fibrillization [43]. The application of FTIR
spectroscopy, a label-free method, may be preferable to probe in vivo the presence of Hfq amyloids.
For this goal, we used a strain allowing tunable expression of various forms of the protein, namely
full-length Hfq (WT), truncated Hfq without amyloid CTR (Hfq-NTR72), and a control hfq deletion.
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We first used strains allowing chromosomic expression of the various forms of Hfq [29].
Nevertheless, the results were ambiguous, probably due to the presence of other amyloidogenic
proteins in E. coli [44]. For this reason, we next used a strain allowing slight overexpression of
Hfq (~5 fold) from a plasmid under the control of an inducible promoter. Note that the strain not
transformed by a plasmid was totally devoid of Hfq (∆hfq), to avoid massive overexpression of Hfq
that could be harmful to the cell [45,46]. After induction, the cells expressing Hfq are recovered by
centrifugation to remove the inducer and culture media. Different plasmids were used allowing the
expression of (i) full-length, (ii) a truncated form of Hfq, Hfq∆CTR (or Hfq-NTR72), and (iii) a control
plasmid lacking Hfq. The corresponding strains will be referred through the manuscript as WT, hfq∆ctr
and ∆hfq, respectively. As shown in Figure 1, we clearly observe a shoulder for the strain expressing
the full-length Hfq protein, compared to strain expressing only the NTR72 part of Hfq (hfq∆ctr) and
that of the control without Hfq (∆hfq), while the Amide II profile is quite similar for all samples, so we
concentrate our analysis in the amide I region.
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Figure 1. FTIR amide spectra of the three different strains WT, hfq∆ctr and ∆hfq.
As seen in Figure 1, no difference was observed in spectra of strains expressing NTR72 (red)
and devoid of Hfq (green), while the strain expressing full-length Hfq was clearly different. Note
that levels of expression of Hfq may slightly vary in different experiences, influencing the spectrum
and the relative secondary structures content. To further investigate in the origin of these differences
and to assign the contribution of the bands to the spectrum, we made difference spectra (Figure 2).
The difference spectra between strains expressing full-length Hfq and totally devoid of Hfq (Figure 2A)
and full-length Hfq and Hfq devoid on its CTR only (Figure 2B) are presented. In Figure 2A,
by subtraction of ∆hfq spectrum from WT spectrum, we have the possibility to evaluate the Amide I of
Hfq-WT protein in vivo, while in Figure 2B subtraction of hfq-∆ctr spectrum from WT spectrum allows
evaluation of the Amide I of Hfq-CTR protein in vivo. These two difference spectra demonstrate
the differences in the region of the intermolecular β-sheet aggregates, the typical IR amyloid bands.
The position of these amyloid peaks is close to that reported for Hfq CTR region in vitro [24].
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Note that Hfq overexpression may result in a change in the expression of other proteins forming
various types of secondary structure. These include unordered structures with signatures between
1640–1648 cm−1 and amyloid structures with signatures ~1620 cm−1. However, Hfq-dependent
pathways usually down-regulate the expression of other proteins, as in the case of CsgD for
example [47]. Indeed, Hfq-dependent sRNAs are known to repress the expression of CsgD [48].
Thus Hfq overexpression will result in a decrease in CsgD expression (or other proteins). Conversely,
Hfq deletion will result in more CsgD and in an increase of amyloid cell content. This is the opposite
of our observation. Thus, we believe that the changes observed in IR spectra are directly related to the
level of Hfq expression, and not to other protein, which expression is dependent on Hfq.Pathogens 2019, 8, x FOR PEER REVIEW 4 of 12 
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Figure 2. Difference spectra. (A) Difference spectrum WT strain − ∆hfq strain. (B) Difference spectrum
WT strain − hfq∆ctr strain. Second derivative analysis of each strain is also presented.
In Figure 3, we report a curve fitting procedure of the total amide I area, which gives us
quantitative details in the secondary structure arrangements of full-length Hfq and Hfq devoid
of its CTR in vivo (reported in Table 1).
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Table 1. Hfq secondary structures content in vivo (in H2O at 20 ◦C) Note that acidic patch at the end of
Hfq is not involved in amyloidog nesis nor i DNA binding properties (no shown).
Amide I Components (cm−1) % Assignment
Hfq full-length in vivo
1614 2 intermolecular β-sheet
1625 5 amyloid β-sheet
1640 14.5 β-sheet
1656 31.5 random coil
1675 11 turns/β-aggregated
1687 13 β-sheet
1710 9 side chains
Hfq-CTR in vivo
1614 2 intermolecular β-sheet
1625 6.5 amyloid β-sheet
1640 12 β-sheet
1656 34 random coil
1674 13 turns/β-aggregated
1687 10 β-sheet
1710 10 side chains
Both the full-length Hfq and the Hfq-CTR (devoid of NTR) difference spectra gave very similar
curve fit ing resu ts wi minor ifferences in the evaluation of the ba d positions and area of a
few p rcent. The β-sheet sig al was s parated into three peaks, one t 1614 cm−1 char cteristic
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of protein aggregation showing that there was little aggregation in the bacteria, one at 1640 cm−1,
assigned to normal β-sheets, and one at 1625 cm−1 assigned to amyloid β-sheet. In amyloids, a peak
at ~ 1615 cm−1 can often be associated with a peak at ~1690 cm−1 (also observed here), and is
attributed to intermolecular β-sheet contacts in mature fibrils and aggregates, while a ~1625 cm−1
can be attributed to intermolecular β-sheet contacts in smaller aggregates. In both in vivo analyses
the amyloid β-sheet signal was approximately half of the β-sheet signal. Previous in vitro FTIR [24],
and Circular Dichroism analyses (Supplementary Figure S1) indicated between 30 and 40% of β-sheet,
in agreement with in vivo analysis. Note that amyloid fibrils formed in vitro or in vivo-isolated may,
however, be structurally different [49]. While the peak at 1687 cm−1 suggests that a part of the protein
adopts an antiparallel β-sheets conformation, the peak at ~1640 cm−1 may also be partially attributed
to the presence of parallel β-sheet [50], a result confirmed by SRCD analysis (Supplementary Figure S1)
using the BESTSEL algorithm [51,52]. The β-sheet specialized algorithm identified 16.6% and 13.8% of
antiparallel and parallel β-sheet respectively (0.015% NMRSD).
2.2. Multivariate Analysis Results
Principal component analysis (PCA) is a multivariate statistical method for analyzing the variance
of multidimensional sets of data, such as the variance in the FTIR spectra. Therefore, we performed
a PCA on the spectra of the three E. coli strains to determine the variability between the different
strains. The results of PCA in the amide I and II domain (1500–1750 cm−1) are shown in Figure 4.
The score plot shows good separation between the WT strain and the two other strains along principal
component 1 (PC1) axis while hfq∆ctr and ∆hfq strains could not be separated (Figure 4A). All WT
strain spectra were classified on the positive side of the PC1 axis while only 5 hfq∆ctr strain and 7 ∆hfq
strain spectra were positive along PC1 (6% and 10% of the spectra respectively). The loading plot
from PC1 (Figure 4B) showed major positive peaks at 1624 and 1710 cm−1 with a strong shoulder at
1696 cm−1 and a negative peak at 1657 cm−1. The profile of PC1 was reminiscent of the difference
spectra between WT and hfq∆ctr and WT and ∆hfq strains (Supplementary Figure S2). PCA loadings
thus showed that WT strain spectra were differentiated from hfq∆ctr and ∆hfq strains spectra by their
stronger absorption at 1710 and 1624 cm−1. The peak at 1624 cm−1 can be tentatively assigned to
the peptide bonds involved in the β-sheet in the amyloid conformation. The peak at 1710 cm−1
was difficult to assign, but it could correspond to acidic amino acids that represent 13% of the CTR
residues (see also Table 1). The shoulder at 1696 cm−1 could correspond to the antiparallel β-sheet
conformation often found at 1690 cm−1 in proteins. PC1 carried 67% of the spectral variance and
showed that the main spectral difference between the three strains was the formation of amyloid
structures by the Hfq protein. All hfq∆ctr and ∆hfq strains spectra that clustered on the positive axis of
PC1 were positioned on the negative side of the PC3 axis separated from the bulk of the WT strain
spectra. PC3 showed major negative peaks at 1550 and 1657 cm−1 and positive peaks at 1630 and 1696
cm−1. This principal component seemed to capture a residual spectral variance related to the amyloid
β−sheet conformation (1630 and 1696 cm−1) that was not captured in PC1, probably due to some
residual baseline artifacts. It is possible that it also captured some signal from aggregated proteins that
can be detected at around 1628 cm−1 in bacteria overexpressing exogenous genes [53]. However, PC3
contribution was small and represented only 5% of the spectral variance. Principal component 2 did
not contribute to the separation between WT and hfq∆ctr and ∆hfq strains. It is likely that PC2 captured
spectral variance linked to the typical variability of the proteome in a bacterial cell population with a
positive peak at 1690 cm−1 and a negative peak at 1633 cm−1 that were not related to the expression of
Hfq. The same signal could be observed when PCA was performed only on the ∆hfq spectra.
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3. Materials and Methods
3.1. E. coli Strains
E. coli BL21(DE3)∆hfq strain was transformed with various plasmids allowing the expression
of Hfq, i.e., full-length or NTR-72 (equivalent Hfq∆CTR) [54]. Plasmids were constructed using a
QuickChange mutagenesis kit (Agilent Technologies, Santa Clara, CA), as previously described [24].
Our choice to use this strain was dictated by a tunable induction level, depending on the induction
condition. As expected, the level of Hfq expressed was higher than that obtained by expression from
the chromosomic copy. Nevertheless, we adapted our conditions (IPTG concentrations and induction
time) to reduce the over-expression to approximately a factor of 5. Three strains expressing different
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forms of Hfq were tested and compared, namely the strain expressing Hfq full-length, CTR-truncated
Hfq Hfq∆CTR = Hfq-NTR72 (residues 1 to 72 of Hfq) and no Hfq (empty plasmid = control strain).
E. coli BL21(DE3)∆hfq transformed strains were grown overnight in LB + ampicillin, diluted and further
grown to an OD600 of 0.5. Hfq expression was turned on using isopropyl β-D-1-thiogalactopyranoside
(IPTG) at 0.05 mM (various incubation time were tested, from 30 min to 3 h). Cells were collected
by centrifugation and washed three times in water. Each culture was repeated at least three times
(independent cultures). Note that Hfq protein devoid of its CTR is less stable than full-length Hfq and
that it is less abundant when expressed in vivo [31]. As shown in sup Figure S3, in our condition we
evaluate that expression of truncated Hfq is 30% less than that of full-length Hfq.
3.2. FTIRSpectroscopy and Principal Components Analysis
For infrared (IR) spectroscopy analysis, we acquired IR transmission spectra by depositing cells
on a CaF2 surface. The deposits were then dried at room temperature and pressure. For each deposit,
thirty spectra were acquired at different positions using a Thermo Scientific IN10 infrared microscope
(Villebon sur Yvette, France) equipped with a DTGS detector, with a 15x Schwarzschild objective and
using an aperture of 100× 100 µm2. Infrared absorption measurements were recorded with a resolution
of 4 cm−1 and a zero filling factor of 2 in the region between 4000 and 400 cm−1 with 128 scans, but only
the region between 1750 and 1500 cm−1 was analyzed and compared for the different strains. Spectra
were first baseline-corrected and then normalized by unit vector normalization. Deconvolution of the
bands has been performed with OMNIC software (Thermo Scientific, Villebon sur Yvette, France),
using the method of the second derivative and curve fitting using a mixed Gaussian/Lorentzian shape.
The 1590–1730 cm−1 range was fitted with eight to nine 20 cm−1-wide peaks with a total of 63 free
parameters for 74 points in the spectral range.
Pre-processed and mean-centered spectra in the 1500–1750 cm−1 region were then subjected to
Principal Component Analysis (PCA) using TheUnscrambler X 10.3 software (CAMO, Oslo, Norway)
with the NIPALS (non-linear iterative partial alternating least square) algorithm and cross-validation
(20 segments of 16 spectra). The PCA was performed with three to four principal components (PCs).
The 95% confidence ellipses were computed in Matlab (Mathworks, Natick, MA) with an in-house script.
3.3. Synchrotron Radiation Circular Dichroism (SRCD)
For SRCD analysis, measurements and data collection were carried out on DISCO beamline at the
SOLEIL Synchrotron (proposal #20180227) [55], as described previously [56]. Two to four microliter
of each sample was loaded into circular demountable CaF2 cells (4.7-micron path length). Separated
data collections were carried out to ensure repeatability. Spectral acquisitions of 1 nm steps at 1.2 s
integration time, between 260 and 175 nm were performed in triplicate for the samples as well as for
the baselines. (+)-camphor-10-sulfonic acid (CSA) was used to calibrate amplitudes and wavelength
positions of the SRCD experiment. Data analyses including averaging, baseline subtraction, smoothing,
scaling and standardization were carried out with CDtool [57]. The data-cutoff was at 175 nm based
on the high tension (HT). Secondary structure content was determined using BestSel [51,52].
4. Conclusions
In this work, we confirm that the E. coli pleiotropic regulator Hfq forms an amyloid structure
in vivo. Precisely, we show that this amyloid assembly is made by the Hfq CTR region and that Hfq
NTR is not implicated in the formation of these structures. This is the first evidence for the presence of
an amyloid structure inside bacteria using a label-free method. Indeed, FTIR can quantitatively and
non-destructively detect amyloids in situ. One important outcome of this work would be to image
the amyloid nanostructures inside the cell using nanoIR, a chemical imaging technique with <10 nm
spatial resolution [58]. This should allow detection of amyloid folding in a cell as small as E. coli cell.
Another continuation of this work would also be to analyze the kinetics of amyloid formation in live
cells in different conditions (planktonic, biofilms or membrane stress for instance).
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